Why Zoetis (ZTS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zoetis Q1 Earnings & Revenues Beat Estimates, '25 Outlook Raised
ZTS reports better-than-expected first-quarter results as earnings and revenues surpass estimates. Management raises 2025 guidance.
Zoetis (ZTS) Surpasses Q1 Earnings and Revenue Estimates
Zoetis (ZTS) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.38 per share a year ago.
Zoetis: Unleashing Margin Expansion; Initiate Strong Buy
We initiate coverage on Zoetis with a Strong Buy rating and a $219.26 price target, driven by explosive growth in companion animal products and structural margin expansion. Zoetis's leadership in c...
Zoetis (ZTS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Zoetis (ZTS) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for som...
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
The stock market has entered a new period of increased uncertainty and volatility following the Trump Administration's desire to reshape America's trade policies. While the market hasn't crashed ou...
Zoetis (ZTS) Advances But Underperforms Market: Key Facts
In the most recent trading session, Zoetis (ZTS) closed at $152.30, indicating a +0.92% shift from the previous trading day.
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this combination today is animal healthcare specialist Zoetis (ZTS 1.93%).
Why Zoetis Stock Took Another Tumble Today
One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (ZTS -4.49%) shares again tumbled. As of late-session trading on Friday, they were dow...
Zoetis Earnings Top Analysts' Forecasts
Zoetis (ZTS -8.79%), the leader in animal health solutions, released its fourth quarter results for 2024 on Feb. 13. The company reported an adjusted earnings per share (EPS) of $1.40, which exceed...
Zoetis forecasts 2025 profit, revenue below estimates; shares fall
Animal healthcare company Zoetis forecast annual profit and revenue below Wall Street estimates on Thursday, partly due to a hit from a stronger dollar, sending its shares down 9% in premarket trad...
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Phibro Animal Health delivers animal health and nutritional solutions through feed additives, vaccines, and performance products. The Zoetis acquisition added 37 product lines, driving a 24% increa...
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
Zoetis (ZTS) closed at $165.02 in the latest trading session, marking a +0.94% move from the prior day.
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?
TROY, Mich. , Jan. 7, 2025 /PRNewswire/ -- Zoetis's recent report has investors wondering if the company's stock is overvalued.
Here's Why Zoetis (ZTS) Gained But Lagged the Market Today
Zoetis (ZTS) closed the most recent trading day at $164.84, moving +0.81% from the previous trading session.
Related Companies